Focus Partners Wealth
MIST icon

Focus Partners Wealth’s Milestone Pharmaceuticals MIST Stock Holding History

Focus Partners Wealth’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.2K Hold
36,000
– – ﹤0.01% 2679
2026
Q1 		$42.8K Hold
36,000
– – ﹤0.01% 2587
2025
Q4 		$72.7K Hold
36,000
– – ﹤0.01% 2581
2025
Q3 		$72K Hold
36,000
– – ﹤0.01% 2147
2025
Q2 		$69.8K Buy
+36,000
New +$48K ﹤0.01% 1963

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Focus Partners Wealth's MIST Position: Q2 2026 in Review

Focus Partners Wealth held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 36,000 shares worth $48.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2679.

Focus Partners Wealth first reported a position in MIST in Q2 2025 and has held it in 5 quarters since. The position peaked at $72.7K in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Focus Partners Wealth held 36,000 shares of Milestone Pharmaceuticals worth $48.2K as of Q2 2026.
  • Focus Partners Wealth left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2679 holding.
  • Focus Partners Wealth first reported a position in Milestone Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Focus Partners Wealth's Milestone Pharmaceuticals position peaked at $72.7K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.